Studies have demonstrated that B[a]P-treated mice exhibited increased levels of Dnmt in the cerebral cortex, causing hypermethylation of the BDNF gene and decreasing BDNF in the brain, resulting in cognitive deficits in mice [131]. This evidence concerns the gene BDNF and Cognitive impairment.